TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Milanova, Viktoriya ^a   Ivanovska, Nina ^a   Dimitrova, Petya ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 17; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TOLL LIKE RECEPTOR 2; ZYMOSAN; CYTOKINE; GAMMA INTERFERON; IL17A PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL CELL; ARTHRITIS; ARTICLE; BLOOD; BONE MARROW; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL FLUID; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; METABOLISM; SCID MOUSE; SYNOVIUM;

ANIMALS; ARTHRITIS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, SCID; NEUTROPHILS; OSTEOPROTEGERIN; PHENOTYPE; RANK LIGAND; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTOR 2;

EID: 84897555974     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/643406     Document Type: Article

References (43)

1. Wright H. L., Chikura B., Bucknall R. C., Moots R. J., Edwards S. W., Changes in expression of membrane TNF, NF- B activation and neutrophil apoptosis during active and resolved inflammation. Annals of the Rheumatic Diseases 2011 70 3 537 543 2-s2.0-79951513066 10.1136/ard.2010.138065
2. Nathan C., Neutrophils and immunity: challenges and opportunities. Nature Reviews Immunology 2006 6 3 173 182 2-s2.0-33344468233 10.1038/nri1785 (Pubitemid 43290987)
3. Sabroe I., Dower S. K., Whyte M. K. B., The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clinical Infectious Diseases 2005 41 supplement 7 S421 S426 2-s2.0-27744558575 10.1086/431992 (Pubitemid 41598299)
4. Ozinsky A., Underhill D. M., Fontenot J. D., Hajjar A. M., Smith K. D., Wilson C. B., Schroeder L., Aderem A., The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proceedings of the National Academy of Sciences of the United States of America 2000 97 25 13766 13771 2-s2.0-0034610291 10.1073/pnas.250476497
5. Takeda K., Akira S., TLR signaling pathways. Seminars in Immunology 2004 16 1 3 9 2-s2.0-0742324860 10.1016/j.smim.2003.10.003 (Pubitemid 38147427)
6. Pålsson-McDermott E. M., O'Neill L. A. J., The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases. Irish Journal of Medical Science 2007 176 4 253 260 2-s2.0-36649027176 10.1007/s11845-007-0103-1 (Pubitemid 50003242)
7. Rosenzweig H. L., Jann M. J., Vance E. E., Planck S. R., Rosenbaum J. T., Davey M. P., Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycan. Arthritis & Rheumatism 2010 62 4 1051 1059 2-s2.0-77950535933 10.1002/art.27335
8. Frasnelli M. E., Tarussio D., Chobaz-Péclat V., Busso N., So A., TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Research & Therapy 2005 7 2 R370 379 2-s2.0-30644473611
9. Raza K., Falciani F., Curnow S. J., Ross E. J., Lee C.-Y., Akbar A. N., Lord J. M., Gordon C., Buckley C. D., Salmon M., Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Research & Therapy 2005 7 4 R784 795 2-s2.0-21644479222
10. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., Saito S., Inoue K., Kamatani N., Gillespie M. T., Martin T. J., Suda T., IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. Journal of Clinical Investigation 1999 103 9 1345 1352 2-s2.0-0033134608 (Pubitemid 29218305)
11. Yamada H., Current perspectives on the role of IL-17 in autoimmune disease. Journal of Inflammation Research 2010 3 1 33 44 2-s2.0-77955538624
12. Kirkham B. W., Lassere M. N., Edmonds J. P., Juhasz K. M., Bird P. A., Lee C. S., Shnier R., Portek I. J., Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis & Rheumatism 2006 54 4 1122 1131 2-s2.0-33646349199 10.1002/art.21749 (Pubitemid 43672925)
13. Kokkonen H., Söderström I., Rocklöv J., Hallmans G., Lejon K., Dahlqvist S. R., Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis & Rheumatism 2010 62 2 383 391 2-s2.0-75749152060 10.1002/art.27186
14. Lubberts E., Joosten L. A. B., Van de Loo F. A. J., Schwarzenberger P., Kolls J., Van den Berg W. B., Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflammation Research 2002 51 2 102 104 2-s2.0-0036192064 (Pubitemid 34183634)
15. Lubberts E., Koenders M. I., Oppers-Walgreen B., Van Den Bersselaar L., Coenen-De Roo C. J. J., Joosten L. A. B., Van Den Berg W. B., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis & Rheumatism 2004 50 2 650 659 2-s2.0-1042267236 10.1002/art.20001 (Pubitemid 38198849)
16. Moran E. M., Mullan R., McCormick J., Connolly M., Sullivan O., FitzGerald O., Bresnihan B., Veale D. J., Fearon U., Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor- α Oncostatin M and response to biologic therapies. Arthritis Research & Therapy 2009 11 4, article R113 2-s2.0-68949158362 10.1186/ar2772
17. Ito H., Yamada H., Shibata T. N., Mitomi H., Nomoto S., Ozaki S., Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis. Arthritis Research & Therapy 2011 13 1, article R14 2-s2.0-79551589436 10.1186/ar3238
18. Yu J. J., Ruddy M. J., Wong G. C., Sfintescu C., Baker P. J., Smith J. B., Evans R. T., Gaffen S. L., An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007 109 9 3794 3802 2-s2.0-34147126728 10.1182/blood-2005-09-010116 (Pubitemid 46641730)
19. Poubelle P. E., Chakravarti A., Fernandes M. J., Doiron K., Marceau A.-A., Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils. Arthritis Research & Therapy 2007 9, article R25 2-s2.0-34047102471 10.1186/ar2137
20. Dimitrova P., Ivanovska N., Belenska L., Abrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis. Arthritis Research & Therapy 2012 14 4 R173
21. Ivanovska N., Dimitrova P., Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine. Arthritis Research & Therapy 2011 13 2, article R44 2-s2.0-79952702582 10.1186/ar3283
22. Dimitrova P., Toncheva A., Gyurkovska V., Ivanovska N., Involvement of soluble receptor activator of nuclear factor- B ligand (sRANKL) in collagenase-induced murine osteoarthritis and human osteoarthritis. Rheumatology International 2012 32 5 1317 1325 2-s2.0-79351469129 10.1007/s00296-010-1723-8
23. Toncheva A., Remichkova M., Ikonomova K., Dimitrova P., Ivanovska N., Inflammatory response in patients with active and inactive osteoarthritis. Rheumatology International 2009 29 10 1197 1203 2-s2.0-68149157380 10.1007/s00296-009-0864-0
24. Dimitrova P., Ivanovska N., Schwaeble W., Gyurkovska V., Stover C., The role of properdin in murine zymosan-induced arthritis. Molecular Immunology 2010 47 7-8 1458 1466 2-s2.0-77950626954 10.1016/j.molimm.2010.02.007
25. Boxio R., Bossenmeyer-Pourié C., Steinckwich N., Dournon C., Nüße O., Mouse bone marrow contains large numbers of functionally competent neutrophils. Journal of Leukocyte Biology 2004 75 4 604 611 2-s2.0-1642424405 10.1189/jlb.0703340 (Pubitemid 38405651)
26. Alves-Filho J. C., Freitas A., Souto F. O., Spiller F., Paula-Neto H., Silva J. S., Gazzinelli R. T., Teixeira M. M., Ferreira S. H., Cunha F. Q., Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proceedings of the National Academy of Sciences of the United States of America 2009 106 10 4018 4023 2-s2.0-62649121369 10.1073/pnas.0900196106
27. Atzeni F., Schena M., Ongari A. M., Carrabba M., Bonara P., Minonzio F., Capsoni F., Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN- γ and IFN- α Cellular Immunology 2002 220 1 20 29 2-s2.0-0036876358 10.1016/S0008-8749(03)00002-9 (Pubitemid 36444496)
28. Daley J. M., Thomay A. A., Connolly M. D., Reichner J. S., Albina J. E., Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. Journal of Leukocyte Biology 2008 83 1 64 70 2-s2.0-38149005534 10.1189/jlb.0407247
29. Barin J. G., Baldeviano G. C., Talor M. V., Wu L., Ong S., Quader F., Chen P., Zheng D., Caturegli P., Rose N. R., Čiháková D., Macrophages participate in IL-17-mediated inflammation. European Journal of Immunology 2012 42 3 726 736 2-s2.0-84859516946 10.1002/eji.201141737
30. Kenna T. J., Brown M. A., The role of IL-17-secreting mast cells in inflammatory joint disease. Nature Review of Rheumatology 2013 9 6 375 379
31. Ferretti S., Bonneau O., Dubois G. R., Jones C. E., Trifilieff A., Il-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- induced airway neutrophilia: IL-15 as a possible trigger. Journal of Immunology 2003 170 4 2106 2112 2-s2.0-0037442137 (Pubitemid 36197433)
32. + neutrophils increase in allergic asthmatic subjects. Allergy Asthma & Clinicalal Immunology 2013 9 1 23 10.1186/1710-1492-9-23
33. Li L., Huang L., Vergis A. L., Ye H., Bajwa A., Narayan V., Strieter R. M., Rosin D. L., Okusa M. D., IL-17 produced by neutrophils regulates IFN- γ -mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. Journal of Clinical Investigation 2010 120 1 331 342 2-s2.0-74949108768 10.1172/JCI38702
34. Lukášová E., Kořistek Z., Falk M., Kozubek S., Grigoryev S., Kozubek M., Ondřej V., Kroupová I., Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities. Journal of Leukocyte Biology 2005 77 1 100 111 2-s2.0-14644389409 10.1189/jlb.0704388 (Pubitemid 40310698)
35. Olins D. E., Olins A. L., Granulocyte heterochromatin: defining the epigenome. BMC Cell Biology 2005 6, article 39 2-s2.0-28044470276 10.1186/1471-2121-6-39 (Pubitemid 41684677)
36. Akimzhanov A. M., Yang X. O., Dong C., Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. The Journal of Biological Chemistry 2007 282 9 5969 5972 2-s2.0-34147138648 10.1074/jbc.C600322200 (Pubitemid 47100812)
37. Novatchkova M., Leibbrandt A., Werzowa J., Neubüser A., Eisenhaber F., The STIR-domain superfamily in signal transduction, development and immunity. Trends in Biochemical Sciences 2003 28 5 226 229 2-s2.0-0038741846 10.1016/S0968-0004(03)00067-7 (Pubitemid 36588662)
38. Kramer J. M., Hanel W., Shen F., Isik N., Malone J. P., Maitra A., Sigurdson W., Swart D., Tocker J., Jin T., Gaffen S. L., Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor. Journal of Immunology 2007 179 10 6379 6383 2-s2.0-38449092511
39. Gaffen S. L., An overview of IL-17 function and signaling. Cytokine 2008 43 3 402 407 2-s2.0-51349111163 10.1016/j.cyto.2008.07.017
40. Hamilton T., Li X., Novotny M., Pavicic P. G. Jr., Datta S., Zhao C., Hartupee J., Sun D., Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression. Journal of Leukocyte Biology 2012 91 3 377 383 2-s2.0-84857812325 10.1189/jlb.0811404
41. Pierer M., Rethage J., Seibl R., Lauener R., Brentano F., Wagner U., Hantzschel H., Michel B. A., Gay R. E., Gay S., Kyburz D., Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. Journal of Immunology 2004 172 4 1256 1265 (Pubitemid 38113789)
42. Parsonage G., Filer A., Bik M., Hardie D., Lax S., Howlett K., Church L. D., Raza K., Wong S.-H., Trebilcock E., Scheel-Toellner D., Salmon M., Lord J. M., Buckley C. D., Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthritis Research & Therapy 2008 10 2, article R47 2-s2.0-44449112665 10.1186/ar2406 (Pubitemid 351757108)
43. Boyce B. F., Xing L., Functions of RANKL/RANK/OPG in bone modeling and remodeling. Archives of Biochemistry & Biophysics 2008 473 2 139 146 2-s2.0-42749083246 10.1016/j.abb.2008.03.018